Alpine Immune Sciences, Inc. (ALPN) financial statements (2022 and earlier)

Company profile

Business Address 188 EAST BLAINE ST., SUITE 200
SEATTLE, WA 98102
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments162,303105,58140,52052,30381,24061,03587,254
Cash and cash equivalents67,90734,95916,12310,7118,00024,20324,991
Short-term investments94,39670,62224,39741,59273,24036,83262,263
Restricted cash and investments  132    
Receivables25,323304100237128  
Prepaid expense720615375445389  
Deferred costs352 15477   
Other undisclosed current assets3,3156011,16083791628432
Total current assets:192,013107,10142,30253,54582,54861,66387,686
Noncurrent Assets
Operating lease, right-of-use asset8,8379,4019,985
Property, plant and equipment1,7161,7851,5521,1961,089175213
Long-term investments and receivables52,86625,549     
Long-term investments52,86625,549     
Intangible assets, net (including goodwill)    1,453  
Intangible assets, net (excluding goodwill)    1,453  
Restricted cash and investments254254254132132  
Deferred income tax assets214  
Other undisclosed noncurrent assets     9710
Total noncurrent assets:63,88736,98911,7911,3282,674272223
TOTAL ASSETS:255,900144,09054,09354,87385,22261,93587,909
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,7666,3596,8285,9935753,8532,864
Accounts payable3,3495821,5431,7161931,921994
Accrued liabilities9,4175,7775,2854,27738253195
Employee-related liabilities     1,8791,675
Deferred revenue51,77331,6271,435
Debt4,6222,5264182,048995  
Deferred rent credit   86
Deferred revenue and credits325  
Other undisclosed current liabilities617655   2,6461,555
Total current liabilities:69,77841,1678,6818,1271,8956,4994,419
Noncurrent Liabilities
Long-term debt and lease obligation14,38919,41715,9382,1554,039  
Long-term debt, excluding current maturities3,3807,6024,5092,1554,039  
Operating lease, liability11,00911,81511,429
Liabilities, other than long-term debt50,83021,348  371  
Deferred revenue and credits66  
Deferred revenue50,83021,348 
Deferred tax liabilities, net 305  
Total noncurrent liabilities:65,21940,76515,9382,1554,410  
Total liabilities:134,99781,93224,61910,2826,3056,4994,419
Stockholders' equity
Stockholders' equity attributable to parent, including:120,90362,15829,47444,59178,91755,43683,490
Common stock     1615
Additional paid in capital287,345177,947117,37190,66488,346235,737232,309
Accumulated other comprehensive income (loss)(273)5310(13)(59)(17)3
Accumulated deficit(166,199)(115,866)(87,926)(46,074)(9,384)(180,300)(148,837)
Other undisclosed stockholders' equity attributable to parent3024191414  
Total stockholders' equity:120,90362,15829,47444,59178,91755,43683,490
TOTAL LIABILITIES AND EQUITY:255,900144,09054,09354,87385,22261,93587,909

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues23,4439,3351,7407051,731  
Revenue, net1,731  
Gross profit:23,4439,3351,7407051,731  
Operating expenses(73,302)(38,084)(45,314)(38,535)(16,705)(31,902)(22,898)
Operating loss:(49,859)(28,749)(43,574)(37,830)(14,974)(31,902)(22,898)
Nonoperating income2551,5782,060 6,601 80
Investment income, nonoperating2592451,248 6,601  
Other nonoperating income (expense)(4)1,333812    
Interest and debt expense(816)(775)(338)(319)(152)  
Loss from continuing operations before equity method investments, income taxes:(50,420)(27,946)(41,852)(38,149)(8,525)(31,902)(22,818)
Other undisclosed income from continuing operations before income taxes   1,296542  
Loss from continuing operations before income taxes:(50,420)(27,946)(41,852)(36,853)(7,983)(31,902)(22,818)
Income tax benefit876 366200  
Net loss:(50,333)(27,940)(41,852)(36,487)(7,783)(31,902)(22,818)
Other undisclosed net income attributable to parent     439 
Net loss available to common stockholders, diluted:(50,333)(27,940)(41,852)(36,487)(7,783)(31,463)(22,818)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(50,333)(27,940)(41,852)(36,487)(7,783)(31,902)(22,818)
Comprehensive loss:(50,333)(27,940)(41,852)(36,487)(7,783)(31,902)(22,818)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(326)432346(59)4193
Comprehensive loss, net of tax, attributable to parent:(50,659)(27,897)(41,829)(36,441)(7,842)(31,483)(22,815)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: